Doug Hampton

Menstrual Cups Market size to grow at a CAGR of 5.18% from 2022 to 2027; Increasing Number of Product Launches Drives Growth -Technavio

by

NEW YORK, June 9, 2023 /PRNewswire/ — The menstrual cups market is estimated to grow by USD 425.44 million from 2022 to 2027. However, the growth momentum will progress at a CAGR of 5.18% during the forecast period. The market is segmented by product (reusable menstrual cups and disposable menstrual cups), distribution channel (retail and online), and geography (North America, … Read more

Growing Number of Research and Development Activities Fuels the Sector

by

DUBLIN, June 9, 2023 /PRNewswire/ — The “Automated Nucleic Acid Extraction Devices Global Market Report 2023” report has been added to  ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the market. The global automated nucleic acid extraction devices market is expected to grow from $4.84 … Read more

Rising Demand for Early Cancer Detection is Significantly Contributing to Growth

by

DUBLIN, June 9, 2023 /PRNewswire/ — The “DNA and Gene Chip Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the market. The global DNA and gene chip market is expected to grow from $6.47 billion in … Read more

Valor Healthcare Awarded Contract to Provide Remote Patient Monitoring Services for the U.S. Department of Veterans Affairs

by

DALLAS, June 9, 2023 /PRNewswire/ — Valor Healthcare is proud to announce its selection as one of four companies awarded a position on Veterans Affairs’ (VA) eight-year, $1.032 billion contract to provide Remote Patient Monitoring (RPM) and Home Telehealth (HT) services for veterans. VA’s Office of Connected Care will deploy the systems and tools needed … Read more

Asep Inc. Signs Definitive Agreement for Joint Venture with Bahrain-based Seaspring W.L.L. for Regulatory Approval and Commercialization of Sepsis Diagnosis Technology in the Kingdom of Bahrain, the Middle East and North Africa

by

Pictured left to right, Dr. Robert E. W. Hancock and Shaikh Isa bin Khalid Al-Khalifa sign the joint venture’s definitive agreement. VANCOUVER, BC, June 9, 2023 /PRNewswire/ – Pursuant to the signing of a Letter of Intent (LOI) in December 2022, Asep Medical Holdings Inc. (“Asep Inc.” or the “Company”) (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is … Read more

FDA Advisory Committee Votes Unanimously to Confirm the Clinical Benefit of LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer’s Disease

by

Peripheral and Central Nervous System Drugs Advisory Committee voted based on data from large global confirmatory Phase 3 Clarity AD clinical trial in patients living with early Alzheimer’s disease The PDUFA action date for traditional approval of LEQEMBI has been set for July 6, 2023, with designation of priority review LEQEMBI received accelerated approval from the … Read more

Global Medical Display Market to 2028

by

DUBLIN, June 9, 2023 /PRNewswire/ — The “Global Medical Display Market by Technology (LED-Backlit LCD Displays, CCFL-Backlit LCD Displays, OLED Displays), Panel Size (Under 22.9 inch panels, 23.9-26.9 inch panels, 27-41.9 inch panels), Resolution, Display Color, Application – Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering. The global market for Medical Display Market … Read more

Sector is Projected to Reach $1.7 Billion by 2029 at a CAGR of 36.1%

by

DUBLIN, June 9, 2023 /PRNewswire/ — The “Global Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics), Application (Therapeutic, Diagnostics), Disease (Cancer, Gastrointestinal, Infectious), Type (Peptide, Live Biotherapeutic Product, FMT), and Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The global human microbiome market is projected to reach USD 1.7 billion by … Read more

FDA ADVISORY COMMITTEE UNANIMOUSLY CONFIRMS EFFICACY AND CLINICAL BENEFIT OF LEQEMBI FOR EARLY ALZHEIMER’S DISEASE

by

CHICAGO, June 9, 2023 /PRNewswire/ — Today, an Advisory Committee to the Food and Drug Administration (FDA) unanimously endorsed the efficacy and clinical benefit of lecanemab (Leqembi™, Eisai) as part of the traditional approval process for this treatment. “The Alzheimer’s Association welcomes and celebrates this action by the FDA Advisory Committee to support traditional approval … Read more

ADDF STATEMENT ON FDA ADVISORY COMMITTEE’S ENDORSEMENT OF LECANEMAB (LEQEMBI)

by

The FDA Advisory Committee’s endorsement of Leqembi ushers in a new era for Alzheimer’s therapeutics Anti-amyloids are not the panacea, underscoring the need to develop novel drugs that can be used in combination therapy approaches NEW YORK, June 9, 2023 /PRNewswire/ — Today, the FDA Peripheral and Central Nervous System Drugs Advisory Committee unanimously voted … Read more